| Display title | Chemistry:SoRI-9409 |
| Default sort key | SoRI-9409 |
| Page length (in bytes) | 2,490 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 323358 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Steve Marsio |
| Date of page creation | 12:43, 6 March 2023 |
| Latest editor | imported>Steve Marsio |
| Date of latest edit | 12:43, 6 March 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | SoRI-9409 is a mixed mu opioid receptor partial agonist and delta opioid receptor antagonist, used in biomedical research. It produces moderate analgesic effects without development of tolerance and with reduced withdrawal symptoms compared to standard opioid analgesics, as well as showing anti-addictive... |
